Clinical Trial Update: EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of methylphenidate on EEG-MRI measures of attention in adults with ADHD and attentional symptoms in mood disorders…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Mood Disorders

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Adult ADHD, Adult-onset ADHD With Mood Disorder | Phase 3 | Status: RECRUITING